Logo Image
News
FDA UpdatesLaw and AdvocacyTechnology TrendsViewpointsAll News
Media
In-Depth InsightsPharmacist ViewScript-EdExpert InterviewsPharmacy PerspectivesPodcastsShorts
Conferences
Conference CoverageConference Listing
Resources
Disease Awareness White Board VideoAmerican Pharmacists MonthSponsored ResourcesCME/CEPartners
More
Publications
Drug Topics JournalTotal Pharmacy JournalSubmission of ArticlesSupplements And Featured Publications
Events
Virtual EventsTotal Pharmacy Solutions Summit
Business
Business StrategiesPatient ServicesPharmacy InventoryLaw and RegulationsTechnology and DataAll Business News
Practice Type
Independent PharmacyChain PharmacySpecialty PharmacyHealth System PharmacyPharmacy Technicians
Total Pharmacy

Subscribe

  • News
  • Media
  • Conferences
  • Resources
  • Publications
  • Events
  • Business
  • Practice Type
  • Subscribe
  • Total Pharmacy
  • Allergy
  • Asthma
  • Autoimmune Diseases
  • Biosimilars
  • COVID-19
  • Cannabidiol (CBD)
  • Cardiology
  • Compounding
  • Continuous Glucose Monitoring
  • Dermatology
  • Diabetes
  • Digestive Health
  • Endocrinology
  • Eye Health
  • Generics
  • HIV
  • Headache and Migraine
  • Immunization
  • Infectious Disease
  • Influenza
  • Insulin Management
  • Medical Devices
  • Mental and Behavioral Health
  • Neurology
  • OTC
  • Obesity Management
  • Oncology
  • Pain Management
    • Nonopioid Pain Management
  • Pediatrics
  • Pneumococcal
  • Public Health
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Shingles
  • Specialty Pharmacy
  • Substance Use Disorder
  • Technology and Data
  • Veterinary Pharmacy
  • Women's Health
  • Wound Care Awareness
Spotlight -
ASHP Midyear |
FDA Updates|
Total Pharmacy
Advertisement

Hannah Buckler, PharmD candidate

Advertisement

Articles by Hannah Buckler, PharmD candidate

Ixazomib for multiple myeloma

ByLisa M. Holle, PharmD, BCOP, FHOPA,Hannah Buckler, PharmD candidate
November 11th 2016

FDA approved ixazomib (Ninlaro, Takeda) in combination with lenalidomide and dexamethasone

Advertisement

Latest Updated Articles

  • Ixazomib for multiple myeloma
    Ixazomib for multiple myeloma

    November 11th 2016



Advertisement
Advertisement

Trending on Drug Topics

1

Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48

2

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages

3

ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain

4

Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches

5

What’s Next for Pneumococcal Vaccination? An Expert Weighs In

  • About
  • Advertise
  • Editorial
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • AdvanCE
  • Total Pharmacy
Drug Topics
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us